| 4 | Statement of changes in beneficial owner... | Milligan Michael Lee | Latham & Watkins Llp (filing Agent) /fa | 02/19/2026 | |
| 4 | Statement of changes in beneficial owner... | Neumora Therapeutics, Inc. | | 02/19/2026 | |
| 4 | Statement of changes in beneficial owner... | Milligan Michael Lee | Latham & Watkins Llp (filing Agent) /fa | 01/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Neumora Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 01/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Milligan Michael Lee | Donnelley Financial Solutions /fa | 05/30/2025 | |
| 4 | Statement of changes in beneficial owner... | Neumora Therapeutics, Inc. | Donnelley Financial Solutions /fa | 05/30/2025 | |
| 4 | Statement of changes in beneficial owner... | Milligan Michael Lee | Latham & Watkins Llp (filing Agent) /fa | 02/20/2025 | |
| 4 | Statement of changes in beneficial owner... | Neumora Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 02/20/2025 | |
| 144 | Filing for proposed sale of securities u... | Milligan Michael Lee | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 02/18/2025 | |
| 4 | Statement of changes in beneficial owner... | Milligan Michael Lee | Donnelley Financial Solutions /fa | 02/18/2025 | |
| Load More |